David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABVX
2001
Abivax
ABVX
$10.2B
| $5.63M | ﹤0.01% |
50,550
+32,950
| +187% | +$3.9M |
|
2002
Keros Therapeutics
KROS
$220M
| $5.63M | ﹤0.01% |
509,608
-245,865
| -33% | -$3.8M |
|
2003
Arcus Biosciences
RCUS
$3.91B
| $5.6M | ﹤0.01% |
259,400
+173,830
| +203% | +$3.75M |
|
2004
AdvanSix
ASIX
$441M
| $5.6M | ﹤0.01% |
229,630
-36,917
| -14% | -$697K |
|
2005
OFG Bancorp
OFG
$2.2B
| $5.6M | ﹤0.01% |
138,335
+49,655
| +56% | +$2.01M |
|
2006
Weibo
WB
$1.72B
| $5.56M | ﹤0.01% |
635,256
-24,988
| -4% | -$251K |
|
|
FPI
2007
Farmland Partners
FPI
$448M
| $5.55M | ﹤0.01% |
494,364
+241,389
| +95% | +$2.77M |
|
2008
Tyler Technologies
TYL
$15.3B
| $5.55M | ﹤0.01% |
16,213
-32,383
| -67% | -$12.1M |
|
2009
PUT
Advance Auto Parts
AAP
$2.6B
| $5.54M | ﹤0.01% |
105,100
+55,000
| +110% | +$2.75M |
|
2010
Sonic Automotive
SAH
$2.49B
| $5.52M | ﹤0.01% |
+80,459
| New | +$5.02M |
|
2011
Samsara
IOT
$24.4B
| $5.52M | ﹤0.01% |
174,087
+163,730
| +1,581% | +$5M |
|
2012
CALL
Medtronic
MDT
$117B
| $5.51M | ﹤0.01% |
63,600
-77,600
| -55% | -$7.43M |
|
2013
Marcus Corp
MCS
$888M
| $5.51M | ﹤0.01% |
320,961
-22,349
| -7% | -$357K |
|
|
BCAX
2014
Bicara Therapeutics
BCAX
$1.67B
| $5.51M | ﹤0.01% |
276,943
+140,421
| +103% | +$2.42M |
|
2015
Royal Gold
RGLD
$22.8B
| $5.51M | ﹤0.01% |
21,644
-47,239
| -69% | -$12.5M |
|
2016
Badger Meter
BMI
$4B
| $5.5M | ﹤0.01% |
36,070
-1,719
| -5% | -$270K |
|
2017
CALL
Caesars Entertainment
CZR
$6.04B
| $5.49M | ﹤0.01% |
207,900
-134,000
| -39% | -$3.19M |
|
|
ALUB
2018
Alussa Energy Acquisition Corp II
ALUB
$364M
| $5.49M | ﹤0.01% |
+550,573
| New | +$5.51M |
|
2019
PUT
SM Energy
SM
$8.55B
| $5.49M | ﹤0.01% |
176,200
+79,200
| +82% | +$1.81M |
|
|
RAPP
2020
Rapport Therapeutics
RAPP
$2.44B
| $5.49M | ﹤0.01% |
175,449
-71,866
| -29% | -$2.02M |
|
|
INFQ
2021
Infleqtion Inc
INFQ
$3.21B
| $5.48M | ﹤0.01% |
+558,791
| New | +$6.36M |
|
2022
CALL
Duolingo
DUOL
$6.77B
| $5.48M | ﹤0.01% |
55,600
+1,000
| +2% | +$123K |
|
2023
Northern Oil and Gas
NOG
$2.74B
| $5.47M | ﹤0.01% |
187,205
-352,673
| -65% | -$9.13M |
|
2024
Organogenesis Holdings
ORGO
$221M
| $5.45M | ﹤0.01% |
2,297,974
+309,495
| +16% | +$1.07M |
|
2025
PUT
Zillow
Z
$7.94B
| $5.45M | ﹤0.01% |
131,600
-3,400
| -3% | -$181K |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.